HTLV-1 p13, a small protein with a busy agenda

Molecular Aspects of Medicine

Volumn 31, Issue 5, 2010, Pages 350-358

  Silic Benussi, Micol ^a   Biasiotto, Roberta ^a   Andresen, Vibeke ^b   Franchini, Genoveffa ^b   D'Agostino, Donna M ^a,c   Ciminale, Vincenzo ^a,c  

^a UNIVERSITY OF PADOVA   (Italy)

^b NATIONAL CANCER INSTITUTE   (United States)

^c VENETO INSTITUTE OF ONCOLOGY IOV IRCCS   (Italy)

Author keywords

Apoptosis; HTLV 1; K+ channel; Leukemia; Mitochondria

Indexed keywords

CALCIUM ION; PROTEIN P12; PROTEIN P13; REACTIVE OXYGEN METABOLITE; TAX PROTEIN; UNCLASSIFIED DRUG; VIRUS PROTEIN;

AMINO ACID SEQUENCE; CALCIUM HOMEOSTASIS; CALCIUM SIGNALING; CELL DEATH; CELL NUCLEUS; CELL PROLIFERATION; HUMAN; HUMAN T CELL LEUKEMIA VIRUS 1; HUMAN T CELL LEUKEMIA VIRUS INFECTION; MITOCHONDRIAL MEMBRANE; NONHUMAN; OXIDATION REDUCTION REACTION; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; PROTEIN TARGETING; REVIEW; T CELL LEUKEMIA; T LYMPHOCYTE ACTIVATION; TROPICAL SPASTIC PARAPARESIS; VIRUS LATENCY;

CELL NUCLEUS; GENE PRODUCTS, TAX; HUMAN T-LYMPHOTROPIC VIRUS 1; HUMANS; MITOCHONDRIA; PROTEIN BINDING; VIRAL PROTEINS;

HUMAN T-LYMPHOTROPIC VIRUS 1;

EID: 77958468041     PISSN: 00982997     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mam.2010.03.001     Document Type: Review

References (47)

1. Ahsan M.K., Masutani H., Yamaguchi Y., Kim Y.C., Nosaka K., Matsuoka M., Nishinaka Y., Maeda M., Yodoi J. Loss of interleukin-2-dependency in HTLV-I-infected T cells on gene silencing of thioredoxin-binding protein-2. Oncogene 2006, 25:2181-2191.
2. Albrecht B., D'Souza C.D., Ding W., Tridandapani S., Coggeshall K.M., Lairmore M.D. Activation of nuclear factor of activated T cells by human T-lymphotropic virus type 1 accessory protein p12(I). J. Virol. 2002, 76:3493-3501.
3. Andresen, V., Pise-Masison, C., Sinha-Datta, U., Washington Parks, R., Cecchinato, V., Fukumoto, R., Nicot, C., Franchini, G. Suppression of HLV-I replication by tax - mediated re-routing of the p13 viral protein to nuclear speckles, submitted for publication.
4. Biasiotto, R., Aguiari, P., Rizzuto, R., Pinton, P., D'Agostino, D.M., Ciminale, V. The p13 protein of human T cell leukemia virus type 1 (HTLV-1) modulates mitochondrial membrane potential and calcium uptake. Biochim Biophys Acta. 2010 Feb 25, [Epub ahead of print].
5. Bouzar A.B., Boxus M., Florins A., Francois C., Reichert M., Willems L. Reduced levels of reactive oxygen species correlate with inhibition of apoptosis, rise in thioredoxin expression and increased bovine leukemia virus proviral loads. Retrovirology 2009, 6:102.
6. Ciminale V., Zotti L., D'Agostino D.M., Ferro T., Casareto L., Franchini G., Bernardi P., Chieco-Bianchi L. Mitochondrial targeting of the p13II protein coded by the x-II ORF of human T-cell leukemia/lymphotropic virus type I (HTLV-I). Oncogene 1999, 18:4505-4514.
7. D'Agostino D.M., Ranzato L., Arrigoni G., Cavallari I., Belleudi F., Torrisi M.R., Silic-Benussi M., Ferro T., Petronilli V., Marin O., et al. Mitochondrial alterations induced by the p13II protein of human T-cell leukemia virus type 1. Critical role of arginine residues. J. Biol. Chem. 2002, 277:34424-34433.
8. D'Agostino D.M., Zotti L., Ferro T., Franchini G., Chieco-Bianchi L., Ciminale V. The p13II protein of HTLV type 1: comparison with mitochondrial proteins coded by other human viruses. AIDS Res. Hum. Retroviruses 2000, 16:1765-1770.
9. Darwiche N., Abou-Lteif G., Bazarbachi A. Reactive oxygen species mediate N-(4-hydroxyphenyl)retinamide-induced cell death in malignant T cells and are inhibited by the HTLV-I oncoprotein Tax. Leukemia 2007, 21:261-269.
10. Ding W., Albrecht B., Kelley R.E., Muthusamy N., Kim S.J., Altschuld R.A., Lairmore M.D. Human T-cell lymphotropic virus type 1 p12(I) expression increases cytoplasmic calcium to enhance the activation of nuclear factor of activated T cells. J. Virol. 2002, 76:10374-10382.
11. Ding W., Albrecht B., Luo R., Zhang W., Stanley J.R., Newbound G.C., Lairmore M.D. Endoplasmic reticulum and cis-Golgi localization of human T-lymphotropic virus type 1 p12(I): association with calreticulin and calnexin. J. Virol. 2001, 75:7672-7682.
12. Ghorbel S., Sinha-Datta U., Dundr M., Brown M., Franchini G., Nicot C. Human T-cell leukemia virus type I p30 nuclear/nucleolar retention is mediated through interactions with RNA and a constituent of the 60 S ribosomal subunit. J. Biol. Chem. 2006, 281:37150-37158.
13. 2+ as a key regulator of cell life and death. Cell Death Differ. 2007, 14:1267-1274.
14. Grassmann R., Aboud M., Jeang K.T. Molecular mechanisms of cellular transformation by HTLV-1 Tax. Oncogene 2005, 24:5976-5985.
15. Harhaj E.W., Good L., Xiao G., Sun S.C. Gene expression profiles in HTLV-I-immortalized T cells: deregulated expression of genes involved in apoptosis regulation. Oncogene 1999, 18:1341-1349.
16. Hasegawa H., Sawa H., Lewis M.J., Orba Y., Sheehy N., Yamamoto Y., Ichinohe T., Tsunetsugu-Yokota Y., Katano H., Takahashi H., et al. Thymus-derived leukemia-lymphoma in mice transgenic for the Tax gene of human T-lymphotropic virus type I. Nat. Med. 2006, 12:466-472.
17. Hiraragi H., Michael B., Nair A., Silic-Benussi M., Ciminale V., Lairmore M. Human T-lymphotropic virus type 1 mitochondrion-localizing protein p13II sensitizes Jurkat T cells to Ras-mediated apoptosis. J. Virol. 2005, 79:9449-9457.
18. Johnson J.M., Nicot C., Fullen J., Ciminale V., Casareto L., Mulloy J.C., Jacobson S., Franchini G. Free major histocompatibility complex class I heavy chain is preferentially targeted for degradation by human T-cell leukemia/lymphotropic virus type 1 p12(I) protein. J. Virol. 2001, 75:6086-6094.
19. Jones K.S., Petrow-Sadowski C., Huang Y.K., Bertolette D.C., Ruscetti F.W. Cell-free HTLV-1 infects dendritic cells leading to transmission and transformation of CD4(+) T cells. Nat. Med. 2008, 14:429-436.
20. Kaimul A.M., Nakamura H., Masutani H., Yodoi J. Thioredoxin and thioredoxin-binding protein-2 in cancer and metabolic syndrome. Free Radic. Biol. Med. 2007, 43:861-868.
21. Kfoury, Y., Nasr, R., Hermine, O., de The, H., Bazarbachi, A., 2005. Proapoptotic regimes for HTLV-I-transformed cells: targeting Tax and the NF-kappaB pathway. Cell Death Differ. 12 (Suppl. 1), 871-877.
22. Koralnik I.J., Fullen J., Franchini G. The p12I, p13II, and p30II proteins encoded by human T-cell leukemia/lymphotropic virus type I open reading frames I and II are localized in three different cellular compartments. J. Virol. 1993, 67:2360-2366.
23. Krammer P.H., Arnold R., Lavrik I.N. Life and death in peripheral T cells. Nat. Rev. Immunol. 2007, 7:532-542.
24. Krueger A., Fas S.C., Giaisi M., Bleumink M., Merling A., Stumpf C., Baumann S., Holtkotte D., Bosch V., Krammer P.H., et al. HTLV-1 Tax protects against CD95-mediated apoptosis by induction of the cellular FLICE-inhibitory protein (c-FLIP). Blood 2006, 107:3933-3939.
25. Lairmore, M., Franchini, G., 2007. Human T-cell leukemia virus types 1 and 2. In: Knipe, D.M., Howley, P.M. (Eds.), Fields Virology, fifth ed. Lippincott Williams and Wilkins, Philadelphia, pp. 2071-2106.
26. Lefebvre L., Ciminale V., Vanderplasschen A., D'Agostino D., Burny A., Willems L., Kettmann R. Subcellular localization of the bovine leukemia virus R3 and G4 accessory proteins. J. Virol. 2002, 76:7843-7854.
27. Lefebvre L., Vanderplasschen A., Ciminale V., Heremans H., Dangoisse O., Jauniaux J.C., Toussaint J.F., Zelnik V., Burny A., Kettmann R., et al. Oncoviral bovine leukemia virus G4 and human T-cell leukemia virus type 1 p13(II) accessory proteins interact with farnesyl pyrophosphate synthetase. J. Virol. 2002, 76:1400-1414.
28. Los M., Khazaie K., Schulze-Osthoff K., Baeuerle P.A., Schirrmacher V., Chlichlia K. Human T cell leukemia virus-I (HTLV-I) Tax-mediated apoptosis in activated T cells requires an enhanced intracellular prooxidant state. J. Immunol. 1998, 161:3050-3055.
29. Masutani H., Hirota K., Sasada T., Ueda-Taniguchi Y., Taniguchi Y., Sono H., Yodoi J. Transactivation of an inducible anti-oxidative stress protein, human thioredoxin by HTLV-I Tax. Immunol. Lett. 1996, 54:67-71.
30. Meuillet E.J., Mahadevan D., Berggren M., Coon A., Powis G. Thioredoxin-1 binds to the C2 domain of PTEN inhibiting PTEN's lipid phosphatase activity and membrane binding: a mechanism for the functional loss of PTEN's tumor suppressor activity. Arch. Biochem. Biophys. 2004, 429:123-133.
31. Mukhopadhyay D., Riezman H. Proteasome-independent functions of ubiquitin in endocytosis and signaling. Science 2007, 315:201-205.
32. Pise-Masison C.A., Radonovich M., Mahieux R., Chatterjee P., Whiteford C., Duvall J., Guillerm C., Gessain A., Brady J.N. Transcription profile of cells infected with human T-cell leukemia virus type I compared with activated lymphocytes. Cancer Res. 2002, 62:3562-3571.
33. Rasola A., Bernardi P. The mitochondrial permeability transition pore and its involvement in cell death and in disease pathogenesis. Apoptosis 2007, 12:815-833.
34. Richardson J.H., Edwards A.J., Cruickshank J.K., Rudge P., Dalgleish A.G. In vivo cellular tropism of human T-cell leukemia virus type 1. J. Virol. 1990, 64:5682-5687.
35. Ruckes T., Saul D., Van Snick J., Hermine O., Grassmann R. Autocrine antiapoptotic stimulation of cultured adult T-cell leukemia cells by overexpression of the chemokine I-309. Blood 2001, 98:1150-1159.
36. Rustin P. Mitochondria, from cell death to proliferation. Nat. Genet. 2002, 30:352-353.
37. Saggioro D., Silic-Benussi M., Biasiotto R., D'Agostino D.M., Ciminale V. Control of cell death pathways by HTLV-1 proteins. Front. Biosci. 2009, 14:3338-3351.
38. Sallusto F., Geginat J., Lanzavecchia A. Central memory and effector memory T cell subsets: function, generation, and maintenance. Annu. Rev. Immunol. 2004, 22:745-763.
39. Salmena L., Pandolfi P.P. Changing venues for tumour suppression: balancing destruction and localization by monoubiquitylation. Nat. Rev. Cancer 2007, 7:409-413.
40. Sasada T., Nakamura H., Masutani H., Ueda S., Sono H., Takabayashi A., Yodoi J. Thioredoxin-mediated redox control of human T cell lymphotropic virus type I (HTLV-I) gene expression. Mol. Immunol. 2002, 38:723-732.
41. Schnell J.R., Chou J.J. Structure and mechanism of the M2 proton channel of influenza A virus. Nature 2008, 451:591-595.
42. Silic-Benussi M., Cannizzaro E., Venerando A., Cavallari I., Petronilli V., La Rocca N., Marin O., Chieco-Bianchi L., Di Lisa F., D'Agostino D.M., et al. Modulation of mitochondrial K(+) permeability and reactive oxygen species production by the p13 protein of human T-cell leukemia virus type 1. Biochim. Biophys. Acta 2009, 1787:947-954.
43. Silic-Benussi, M., Cavallari, I., Vajente, N., Vidali, S., Chieco-Bianchi, L., Di Lisa, F., Saggioro, D., D'Agostino, D.M., Ciminale, V. Redox regulation of T-cell turnover by the p13 protein of human T-cell leukemia virus type 1: distinct effects in primary vs. transformed cells, submitted for publication.
44. Silic-Benussi M., Cavallari I., Zorzan T., Rossi E., Hiraragi H., Rosato A., Horie K., Saggioro D., Lairmore M.D., Willems L., et al. Suppression of tumor growth and cell proliferation by p13II, a mitochondrial protein of human T cell leukemia virus type 1. Proc. Natl. Acad. Sci. USA 2004, 101:6629-6634.
45. Trachootham D., Alexandre J., Huang P. Targeting cancer cells by ROS-mediated mechanisms: a radical therapeutic approach?. Nat. Rev. Drug Discov. 2009, 8:579-591.
46. Williams M.S., Kwon J. T cell receptor stimulation, reactive oxygen species, and cell signaling. Free Radic. Biol. Med. 2004, 37:1144-1151.
47. Yodoi J., Tursz T. ADF, a growth-promoting factor derived from adult T cell leukemia and homologous to thioredoxin: involvement in lymphocyte immortalization by HTLV-I and EBV. Adv. Cancer Res. 1991, 57:381-411.